![]() |
![]() |
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
![]()
| Center | Date | Time | Location |
|---|---|---|---|
| CDRH | August 25, 2005 August 26, 2005 |
8:00 a.m. - 6:00
p.m. 8:00 a.m. - 6:00 p.m. |
Hilton Washington
DC North |
Agenda:
On August 25, 2005, the committee will hear a presentation on the FDA Critical
Path Initiative and a presentation by the Office of Surveillance and Biometrics
in the Center for Devices and Radiological Health outlining their responsibility
for the review of postmarket study design.
On August 25 and 26, 2005, the committee will discuss and make recommendations on the classification of five preamendments medical devices: Bone wax, medical maggots, medicinal leeches, tissue expander, and wound dressing with a drug.
Background material and meeting information will become available no later than one business day before the each meeting day (Simply scroll down to the appropriate committee heading).
Procedure:
Interested persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made to the
contact person by August 11, 2005. On August 25, 2005, oral presentations from
the public will be scheduled between approximately 10:15 a.m. and 10:45 a.m.,
1:45 p.m. and 2:15 p.m., and 4:30 p.m. and 5 p.m. On August 26, 2005, oral presentations
from the public will be scheduled between approximately 9:30 a.m. and 10 a.m.,
1 p.m. and 1:30 p.m., and 3:45 p.m. and 4:15 p.m. Time allotted for each presentation
may be limited. Those desiring to make formal oral presentations should notify
the contact person before August 11, 2005, and submit a brief statement of the
general nature of the evidence or arguments they wish to present, the names
and addresses of proposed participants, and an indication of the approximate
time requested to make their presentation. Persons attending FDA's advisory
committee meetings are advised that the agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the public at its advisory committee meetings
and will make every effort to accommodate persons with physical disabilities
or special needs. If you require special accommodations due to a disability,
please contact AnnMarie Williams, Conference Management Staff, at 240-276-0450,
ext. 113, at least 7 days in advance of the meeting.
Contact Person:
David Krause, Center for Devices and Radiological Health (HFZ-410), Food and
Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-3090,
ext. 141.
Advisory Committee Telephone Information Line:
Please call the Information Line for up-to-date information on this
meeting, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512519.
![]()